Discover open access scientific publications

Search, annotate, share and cite publications

Publications by J.T. George

Consistent Cardiovascular (CV) Benefit of Empagliflozin Over the Spectrum of CV Risk Factor Control in EMPA-REG OUTCOME

Metabolism: Clinical and Experimental
EndocrinologyMetabolismDiabetes
2020English

Pdb63 - Cost-Effectiveness Analysis of Empagliflozin Treatment in Patients With Type 2 Diabetes and Chronic Heart Failure Based on Subgroup of Empa-Reg Outcome in the United Kingdom

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Related publications

EMPA-REG OUTCOME: The Endocrinologist's Point of View

American Journal of Medicine
Medicine
2017English

EMPA-REG OUTCOME: The Nephrologist's Point of View

American Journal of Cardiology
Cardiovascular MedicineCardiology
2017English

EMPA-REG OUTCOME: The Cardiologist's Point of View

American Journal of Cardiology
Cardiovascular MedicineCardiology
2017English

Following the Results of the EMPA-REG OUTCOME Trial With Empagliflozin, Is It Possible to Speak of a Class Effect?

International Journal of General Medicine
Medicine
2017English

Pdb62 - Cost-Effectiveness Analysis of Empagliflozin in Japan Based on Results From the Subgroup Analysis of Asian Patients in the Empa-Reg Outcome Trial

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Mortality Reduction in EMPA-REG OUTCOME Trial: Beyond the Antidiabetes Effect

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2018English

Empa's New Clothes: The Untold Story of the Empa-Reg Outcome Trial

Diabetes Technology and Therapeutics
MedicineEndocrinologyMedical Laboratory TechnologyMetabolismDiabetes
2017English

DECLARE-TIMI 58 Trial in the Context of EMPA-REG OUTCOME and CANVAS

Diabetes Mellitus
Internal MedicineEndocrinologyMetabolismDiabetes
2020English

Erratum. Mitigating Cardiovascular Risk in Type 2 Diabetes With Antidiabetes Drugs: A Review of Principal Cardiovascular Outcome Results of EMPA-REG OUTCOME, LEADER, and SUSTAIN-6 Trials. Diabetes Care 2017;40:821–831

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy